New MRI scan could replace needle biopsy for liver scarring
NCT ID NCT06703450
First seen May 02, 2026 · Last updated May 12, 2026 · Updated 1 time
Summary
This study aims to see if a special MRI scan can accurately measure liver scarring in people with MASH, a type of fatty liver disease. Researchers will compare the MRI results with standard tests like ultrasound and blood work. The goal is to find a noninvasive way to diagnose liver fibrosis without needing a needle biopsy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mount Sinai
New York, New York, 10029, United States
Conditions
Explore the condition pages connected to this study.